<?xml
version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel xml:lang="fr">
	<title>Joseph Larmarange</title>
	<link>https://joseph.larmarange.net/</link>
	<description>D&#233;mographe en sant&#233; publique, directeur de recherche HDR &#224; l'IRD,directeur adjoint du Ceped (UMR 196 Universit&#233; Paris Cit&#233;, IRD, Universit&#233; Sorbonne Paris Nord, Inserm)</description>
	<language>fr</language>
	<generator>SPIP - www.spip.net</generator>
	<atom:link href="https://www.joseph.larmarange.net/spip.php?id_mot=10&amp;page=backend" rel="self" type="application/rss+xml" />

	<image>
		<title>Joseph Larmarange</title>
		<url>https://www.joseph.larmarange.net/local/cache-vignettes/L144xH52/joseph_larmarange_site-6e82f.svg?1649686173</url>
		<link>https://joseph.larmarange.net/</link>
		<height>52</height>
		<width>144</width>
	</image>



<item xml:lang="fr">
		<title>FLUID &#183; D&#233;veloppement d'une cohorte longitudinale sur la fluidit&#233; sexuelle chez les jeunes adultes au Canada, en France et au Royaume-Uni</title>
		<link>https://www.joseph.larmarange.net/fluid-developpement-d-une-cohorte</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/fluid-developpement-d-une-cohorte</guid>
		<dc:date>2025-02-28T14:20:09Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>France</dc:subject>
		<dc:subject>Canada</dc:subject>
		<dc:subject>Royaume-Uni</dc:subject>
		<dc:subject>FLUID</dc:subject>
		<dc:subject>Approches biographiques</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>Fluidit&#233; sexuelle</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>Identit&#233;s sexuelles</dc:subject>
		<dc:subject>In&#233;galit&#233;s de genre</dc:subject>
		<dc:subject>Jeunes</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>Relations de genre</dc:subject>
		<dc:subject>Sant&#233; mentale</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>

		<description>
&lt;p&gt;Responsable scientifique Pierre-Julien Coulaud (CERPOP) &lt;br class='autobr' /&gt;
Partenaires Centre d'Epid&#233;miologie et de Recherche en sant&#233; des POPulations (CERPOP UMR1295, Universit&#233; de Toulouse, Inserm) &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; https://cerpop.inserm.fr/ Ceped (UMR 196, Universit&#233; Paris Cit&#233;, IRD,, Universit&#233; Sorbonne Paris Nord, Inserm) &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; httsp&#160;://www.ceped.org &#201;cole de sant&#233; publique de l'Universit&#233; de Montr&#233;al (ESPUM) &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; https://espum.umontreal.ca/ Robert Gordon University &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; https://www.rgu.ac.uk/ &lt;br class='autobr' /&gt;
Financement ANRS | MIE &lt;br class='autobr' /&gt;
R&#233;sum&#233;&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Projets-de-Recherche-" rel="directory"&gt;Projets de Recherche&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-France-+" rel="tag"&gt;France&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-canada-+" rel="tag"&gt;Canada&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-royaume-uni-+" rel="tag"&gt;Royaume-Uni&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-fluid-+" rel="tag"&gt;FLUID&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Approches-biographiques-+" rel="tag"&gt;Approches biographiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-fluidite-sexuelle-+" rel="tag"&gt;Fluidit&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Identites-sexuelles-+" rel="tag"&gt;Identit&#233;s sexuelles&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Inegalites-de-genre-+" rel="tag"&gt;In&#233;galit&#233;s de genre&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Jeunes-+" rel="tag"&gt;Jeunes&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Relations-de-genre-+" rel="tag"&gt;Relations de genre&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-sante-mentale-+" rel="tag"&gt;Sant&#233; mentale&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH150/designer-d1202.jpg?1740754220' class='spip_logo spip_logo_right' width='150' height='150' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Responsable scientifique&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Pierre-Julien Coulaud (CERPOP)&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Partenaires&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Centre d'Epid&#233;miologie et de Recherche en sant&#233; des POPulations (CERPOP UMR1295, Universit&#233; de Toulouse, Inserm) &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; &lt;a href=&#034;https://cerpop.inserm.fr/&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;https://cerpop.inserm.fr/&lt;/a&gt;&lt;/li&gt;&lt;li&gt; Ceped (UMR 196, Universit&#233; Paris Cit&#233;, IRD,, Universit&#233; Sorbonne Paris Nord, Inserm) &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; httsp&#160;://&lt;a href=&#034;http://www.ceped.org&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;www.ceped.org&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &#201;cole de sant&#233; publique de l'Universit&#233; de Montr&#233;al (ESPUM) &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; &lt;a href=&#034;https://espum.umontreal.ca/&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;https://espum.umontreal.ca/&lt;/a&gt;&lt;/li&gt;&lt;li&gt; Robert Gordon University &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; &lt;a href=&#034;https://www.rgu.ac.uk/&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;https://www.rgu.ac.uk/&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Financement&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; ANRS | MIE&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
R&#233;sum&#233;&lt;/h2&gt;
&lt;p&gt;La g&#233;n&#233;ration actuelle de jeunes (18-30 ans) arrive &#224; un &#226;ge o&#249; la fa&#231;on dont la sexualit&#233; est per&#231;ue et v&#233;cue change profond&#233;ment. Des recherches ont montr&#233; que les jeunes connaissent des changements d'orientation sexuelle au cours du temps (aussi appel&#233;s fluidit&#233; sexuelle), notamment des changements d'attirances, d'identit&#233;s et/ou de comportements sexuels. De nouvelles donn&#233;es d&#233;montrent aussi que la fluidit&#233; sexuelle est un d&#233;terminant essentiel des in&#233;galit&#233;s en mati&#232;re de sant&#233; sexuelle, de sant&#233; mentale, de consommation de substances et de maladies chroniques. De plus, des &#233;tudes sugg&#232;rent que des facteurs contextuels (par exemple, les normes de genre, le climat politique) peuvent influencer les exp&#233;riences de fluidit&#233; sexuelle, mettant en avant le besoin de mener des &#233;tudes comparatives entre pays pour mieux appr&#233;hender le r&#244;le de ces facteurs. Des approches de recherche innovantes sont ainsi n&#233;cessaires pour comprendre comment &#233;volue la sexualit&#233; des jeunes dans le contexte actuel.&lt;/p&gt;
&lt;p&gt;Pour combler ces lacunes, notre objectif est de d&#233;velopper une nouvelle &#233;tude de cohorte longitudinale sur la fluidit&#233; sexuelle chez les jeunes au Canada, en France et au Royaume-Uni (RU). Pour cela, une &#233;tude pilote permettra d'identifier les mesures et les m&#233;thodes adapt&#233;es pour &#233;valuer au mieux la diversit&#233; et la complexit&#233; des mod&#232;les et des trajectoires de fluidit&#233; sexuelle chez les jeunes. Cette &#233;tude offrira la possibilit&#233; d'&#233;tablir des partenariats avec des leaders communautaires et des chercheurs locaux et internationaux qui faciliteront le d&#233;veloppement de notre futur programme de recherche sur la fluidit&#233; sexuelle.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Mots-Cl&#233;s&lt;/h2&gt;
&lt;p&gt;Fluidit&#233; sexuelle, orientation sexuelle, normes de genre, sant&#233; sexuelle, sant&#233; mentale&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Zone g&#233;ographique&lt;/h2&gt;
&lt;p&gt;Canada, France, Royaume-Uni&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Calendrier&lt;/h2&gt;
&lt;p&gt;2025-2027&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>D&#233;crire les &#233;pid&#233;mies, Comprendre les populations&#160;: une d&#233;mographie du VIH en Afrique subsaharienne</title>
		<link>https://www.joseph.larmarange.net/hdr</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/hdr</guid>
		<dc:date>2022-10-14T06:38:12Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>ATLAS</dc:subject>
		<dc:subject>CAP-CoV-Soignants-BF</dc:subject>
		<dc:subject>DOD-CI (ANRS 12287 / 12323)</dc:subject>
		<dc:subject>ELIHoS (ANRS 12139)</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>Pr&#233;valences du VIH (ANRS 12114)</dc:subject>
		<dc:subject>prevR</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>TasP (ANRS 12249)</dc:subject>
		<dc:subject>Afrique du Sud</dc:subject>
		<dc:subject>Burkina Faso</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Mali</dc:subject>
		<dc:subject>S&#233;n&#233;gal</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Analyse de s&#233;quences</dc:subject>
		<dc:subject>Approches biographiques</dc:subject>
		<dc:subject>Approches communautaires</dc:subject>
		<dc:subject>Autotests VIH</dc:subject>
		<dc:subject>Cartographie</dc:subject>
		<dc:subject>Cascade des soins</dc:subject>
		<dc:subject>Comparaison de cohortes</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>D&#233;mographie</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>EDS (Enqu&#234;tes D&#233;mographiques et de Sant&#233;)</dc:subject>
		<dc:subject>Enqu&#234;tes par t&#233;l&#233;phone</dc:subject>
		<dc:subject>Enseignement acad&#233;mique</dc:subject>
		<dc:subject>Lien vers les soins</dc:subject>
		<dc:subject>&#201;pid&#233;miologie</dc:subject>
		<dc:subject>Essais cliniques</dc:subject>
		<dc:subject>Estimateurs &#224; noyau (kernel density estimation)</dc:subject>
		<dc:subject>Femmes enceintes</dc:subject>
		<dc:subject>Financement des programmes</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>Identit&#233;s sexuelles</dc:subject>
		<dc:subject>Incidence du VIH</dc:subject>
		<dc:subject>Interpolation spatiale</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Itin&#233;raires th&#233;rapeutiques</dc:subject>
		<dc:subject>Masculinit&#233;s</dc:subject>
		<dc:subject>M&#233;nages</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>M&#233;thodologie</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Observatoire de population</dc:subject>
		<dc:subject>Partenaires sexuel(le)s</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;valence du VIH</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;</dc:subject>
		<dc:subject>Repr&#233;sentations / Perceptions</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Structure des populations</dc:subject>
		<dc:subject>Structures de sant&#233;</dc:subject>
		<dc:subject>Surveillance sentinelle</dc:subject>
		<dc:subject>T&#233;l&#233;phones mobiles</dc:subject>
		<dc:subject>Temporalit&#233;s</dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>
		<dc:subject>Universal Test &amp; Treat (UTT)</dc:subject>
		<dc:subject>Usager&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;e&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;s de drogue</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Habilitation &#224; Diriger des Recherches soutenue le 12&#160;octobre 2012 par Joseph Larmarange &#224; l'Universit&#233; Paris Cit&#233;. &lt;br class='autobr' /&gt; D&#233;crire les &#233;pid&#233;mies, Comprendre les populations&#160;: une d&#233;mographie du VIH en Afrique subsaharienne &lt;br class='autobr' /&gt; Joseph Larmarange D&#233;mographie. Universit&#233; Paris Cit&#233;, 2022 HDR tel-03814024&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-ATLAS-+" rel="tag"&gt;ATLAS&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-CAP-CoV-Soignants-BF-+" rel="tag"&gt;CAP-CoV-Soignants-BF&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-DOD-CI-ANRS-12287-+" rel="tag"&gt;DOD-CI (ANRS 12287 / 12323)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-ELIHoS-ANRS-12139-+" rel="tag"&gt;ELIHoS (ANRS 12139)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevalences-du-VIH-ANRS-12114-+" rel="tag"&gt;Pr&#233;valences du VIH (ANRS 12114)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-prevR-+" rel="tag"&gt;prevR&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-TasP-ANRS-12249-97-+" rel="tag"&gt;TasP (ANRS 12249)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Afrique-du-Sud-+" rel="tag"&gt;Afrique du Sud&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Burkina-Faso-+" rel="tag"&gt;Burkina Faso&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mali-+" rel="tag"&gt;Mali&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Senegal-+" rel="tag"&gt;S&#233;n&#233;gal&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Analyse-de-sequences-+" rel="tag"&gt;Analyse de s&#233;quences&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Approches-biographiques-+" rel="tag"&gt;Approches biographiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Approches-communautaires-+" rel="tag"&gt;Approches communautaires&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Autotests-VIH-+" rel="tag"&gt;Autotests VIH&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cartographie-+" rel="tag"&gt;Cartographie&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cascade-des-soins-+" rel="tag"&gt;Cascade des soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Comparaison-de-cohortes-+" rel="tag"&gt;Comparaison de cohortes&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Demographie-+" rel="tag"&gt;D&#233;mographie&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-EDS-Enquetes-Demographiques-et-de-+" rel="tag"&gt;EDS (Enqu&#234;tes D&#233;mographiques et de Sant&#233;)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Enquetes-par-telephone-+" rel="tag"&gt;Enqu&#234;tes par t&#233;l&#233;phone&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Enseignement-academique-+" rel="tag"&gt;Enseignement acad&#233;mique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Entree-en-soins-+" rel="tag"&gt;Lien vers les soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Epidemiologie-+" rel="tag"&gt;&#201;pid&#233;miologie&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Essais-cliniques-+" rel="tag"&gt;Essais cliniques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Estimateurs-a-noyau-kernel-density-+" rel="tag"&gt;Estimateurs &#224; noyau (kernel density estimation)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Femmes-enceintes-+" rel="tag"&gt;Femmes enceintes&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Financement-des-programmes-+" rel="tag"&gt;Financement des programmes&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Identites-sexuelles-+" rel="tag"&gt;Identit&#233;s sexuelles&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Incidence-du-VIH-+" rel="tag"&gt;Incidence du VIH&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Interpolation-spatiale-+" rel="tag"&gt;Interpolation spatiale&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Itineraires-therapeutiques-+" rel="tag"&gt;Itin&#233;raires th&#233;rapeutiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Masculinites-+" rel="tag"&gt;Masculinit&#233;s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Menages-+" rel="tag"&gt;M&#233;nages&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Methodologie-+" rel="tag"&gt;M&#233;thodologie&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Observatoire-de-population-+" rel="tag"&gt;Observatoire de population&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Partenaires-sexuel-le-s-+" rel="tag"&gt;Partenaires sexuel(le)s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevalence-du-VIH-+" rel="tag"&gt;Pr&#233;valence du VIH&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recrutement-boules-de-neige-+" rel="tag"&gt;Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Representations-Perceptions-+" rel="tag"&gt;Repr&#233;sentations / Perceptions&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Structure-des-populations-+" rel="tag"&gt;Structure des populations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Structures-de-sante-+" rel="tag"&gt;Structures de sant&#233;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Surveillance-sentinelle-+" rel="tag"&gt;Surveillance sentinelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Telephones-mobiles-+" rel="tag"&gt;T&#233;l&#233;phones mobiles&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Temporalites-142-+" rel="tag"&gt;Temporalit&#233;s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Universal-Test-Treat-UTT-+" rel="tag"&gt;Universal Test &amp; Treat (UTT)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Usagers-de-drogue-par-voie-+" rel="tag"&gt;Usager&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;e&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;s de drogue&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH109/ruban_spirales-a3fec.png?1715097926' class='spip_logo spip_logo_right' width='150' height='109' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Habilitation &#224; Diriger des Recherches soutenue le 12&#160;octobre 2012 par Joseph Larmarange &#224; l'Universit&#233; Paris Cit&#233;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-3814024&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://theses.hal.science/tel-03814024v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-877a2ad2-17cac.png?1702907846' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://theses.hal.science/tel-03814024v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;D&#233;crire les &#233;pid&#233;mies, Comprendre les populations : une d&#233;mographie du VIH en Afrique subsaharienne&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;D&#233;mographie. Universit&#233; Paris Cit&#233;, 2022&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-hdr&#034;&gt;HDR&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://theses.hal.science/tel-03814024v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;tel-03814024&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;iframe width=&#034;100%&#034; height=&#034;500&#034; src=&#034;https://www.youtube.com/embed/me6rDSq0p0k&#034; title=&#034;YouTube video player&#034; frameborder=&#034;0&#034; allow=&#034;accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;h2 class=&#034;spip&#034;&gt;
Jury&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Didier Breton (Universit&#233; de Strasbourg, rapporteur)&lt;/li&gt;&lt;li&gt; Val&#233;rie Delauney (IRD, rapportrice)&lt;/li&gt;&lt;li&gt; Annabel Desgr&#233;es du Lo&#251; (IRD, garante)&lt;/li&gt;&lt;li&gt; G&#233;raldine Duth&#233; (Ined, rapportrice)&lt;/li&gt;&lt;li&gt; Didier Ekouevi (Inserm, Universit&#233; de Lom&#233;, examinateur)&lt;/li&gt;&lt;li&gt; V&#233;ronique Petit (Universit&#233; Paris Cit&#233;, pr&#233;sidente)&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/hdr_larmarange_v2022-10-12.pdf" length="15224200" type="application/pdf" />
		

	</item>
<item xml:lang="fr">
		<title>La PrEP seule ne suffit pas&#160;: elle doit &#234;tre accompagn&#233;e d'une offre de soins globale</title>
		<link>https://www.joseph.larmarange.net/La-PrEP-seule-ne-suffit-pas-elle</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/La-PrEP-seule-ne-suffit-pas-elle</guid>
		<dc:date>2022-05-19T09:49:15Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>Contraception</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>

		<description>
&lt;p&gt;Cette note de politique, pr&#233;par&#233;e par PAC-CI, repose sur des r&#233;sultats du projet PrEP-CI ANRS 12361. &lt;br class='autobr' /&gt; La PrEP seule ne suffit pas&#160;: elle doit &#234;tre accompagn&#233;e d'une offre de soins globale &lt;br class='autobr' /&gt; Alexandra Bitty-Anderson , Annick Gui&#233; , Eulalie Kanga , Marcellin Nouaman ,&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Contraception-+" rel="tag"&gt;Contraception&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L100xH150/dsc03314-1d274.jpg?1715146422' class='spip_logo spip_logo_right' width='100' height='150' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Cette note de politique, pr&#233;par&#233;e par PAC-CI, repose sur des r&#233;sultats du projet &lt;a href='https://www.joseph.larmarange.net/Etude-de-faisabilite-en-vue-d-un' class=&#034;spip_in&#034;&gt;PrEP-CI ANRS 12361&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-3882265&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://ird.hal.science/ird-03882265v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-bb4eaea8-b9e24.png?1702930409' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-03882265v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;La PrEP seule ne suffit pas : elle doit &#234;tre accompagn&#233;e d'une offre de soins globale&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Alexandra+Bitty-Anderson&#034; class=&#034;hal-auteur&#034;&gt;Alexandra Bitty-Anderson&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Annick+Gui%C3%A9&#034; class=&#034;hal-auteur&#034;&gt;Annick Gui&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Eulalie+Kanga&#034; class=&#034;hal-auteur&#034;&gt;Eulalie Kanga&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marcellin+Nouaman&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;Note de politique PAC-CI #3, Programme PAC-CI. 2022&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-report&#034;&gt;Rapport&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-03882265v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;ird-03882265&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;figure class='spip_document_457 spip_documents media_pdfjs media_application media_application_pdf'&gt; &lt;!--[if !IE]&gt;&lt;!--&gt;&lt;iframe src=&#034;spip.php?page=pdfjs&amp;id_document=457&#034; width=&#034;100%&#034; height=&#034;600&#034; style=&#034;border: none;&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;!--&lt;![endif]--&gt; &lt;!--[if IE]&gt;&lt;iframe src=&#034;IMG/pdf/prep-ci_note_de_politique_prep_et_offre_sante_globale.pdf&#034; width=&#034;100%&#034; height=&#034;600&#034; style=&#034;border: none;&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;![endif]--&gt; &lt;/figure&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>A community-based healthcare package combining testing and prevention tools, including pre-exposure prophylaxis (PrEP), immediate HIV treatment, management of hepatitis B virus, and sexual and reproductive health (SRH), targeting female sex workers (FSWs) in C&#244;te d'Ivoire: the ANRS 12381 PRINCESSE project</title>
		<link>https://www.joseph.larmarange.net/A-community-based-healthcare</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/A-community-based-healthcare</guid>
		<dc:date>2021-12-06T09:50:35Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Approches communautaires</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Essais cliniques</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>In&#233;galit&#233;s de genre</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Itin&#233;raires th&#233;rapeutiques</dc:subject>
		<dc:subject>Organisation des soins</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Protocol paper of the ANRS 12381 PRINCESSE project. &lt;br class='autobr' /&gt;
Authors &lt;br class='autobr' /&gt;
Valentine Becquet, Marcellin Nouaman, M&#233;lanie Plazy, Aline Agoua, Cl&#233;mence Z&#233;bago, Herv&#233; Dao, Alice Montoyo, Aude Jary, Patrick A. Coffie, Serge Eholi&#233;, Joseph Larmarange &amp; and the ANRS 12381 PRINCESSE team &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Background &lt;br class='autobr' /&gt;
Pre-exposure prophylaxis (PrEP) is recommended by the WHO for HIV prevention among female sex workers (FSWs). A study conducted in 2016&#8211;2017 in C&#244;te d'Ivoire showed that if PrEP is acceptable,&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Approches-communautaires-+" rel="tag"&gt;Approches communautaires&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Essais-cliniques-+" rel="tag"&gt;Essais cliniques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Inegalites-de-genre-+" rel="tag"&gt;In&#233;galit&#233;s de genre&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Itineraires-therapeutiques-+" rel="tag"&gt;Itin&#233;raires th&#233;rapeutiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Organisation-des-soins-+" rel="tag"&gt;Organisation des soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH112/arton302-9604f.jpg?1763089085' class='spip_logo spip_logo_right' width='150' height='112' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Protocol paper of the &lt;a href='https://www.joseph.larmarange.net/PRINCESSE-PrEP-infections' class=&#034;spip_in&#034; hreflang=&#034;fr&#034;&gt;ANRS 12381 PRINCESSE project&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-3467822&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-03467822v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L57xH75/thumb-e92fcf30-16f53.png?1702910744' alt=&#034;Image document&#034; width='57' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-03467822v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;A community-based healthcare package combining testing and prevention tools, including pre-exposure prophylaxis (PrEP), immediate HIV treatment, management of hepatitis B virus, and sexual and reproductive health (SRH), targeting female sex workers (FSWs) in C&#244;te d'Ivoire: the ANRS 12381 PRINCESSE project&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marcellin+Nouaman&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Aline+Agoua&#034; class=&#034;hal-auteur&#034;&gt;Aline Agoua&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Cl%C3%A9mence+Z%C3%A9bago&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Z&#233;bago&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Herv%C3%A9+Dao&#034; class=&#034;hal-auteur&#034;&gt;Herv&#233; Dao&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Alice+Montoyo&#034; class=&#034;hal-auteur&#034;&gt;Alice Montoyo&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/aude-jary&#034; class=&#034;hal-auteur&#034;&gt;Aude Jary&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Patrick+A.+Coffie&#034; class=&#034;hal-auteur&#034;&gt;Patrick A. Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Serge+Eholi%C3%A9&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;BMC Public Health&lt;/i&gt;, 2021, 21 (1), pp.2214. &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.1186/s12889-021-12235-0&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.1186/s12889-021-12235-0&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-03467822v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-03467822&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Valentine Becquet, Marcellin Nouaman, M&#233;lanie Plazy, Aline Agoua, Cl&#233;mence Z&#233;bago, Herv&#233; Dao, Alice Montoyo, Aude Jary, Patrick A. Coffie, Serge Eholi&#233;, Joseph Larmarange &amp; and the ANRS 12381 PRINCESSE team&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Background&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Pre-exposure prophylaxis (PrEP) is recommended by the WHO for HIV prevention among female sex workers (FSWs). A study conducted in 2016&#8211;2017 in C&#244;te d'Ivoire showed that if PrEP is acceptable, FSWs also have many uncovered sexual health needs. Based on this evidence, the ANRS 12381 PRINCESSE project was developed in collaboration with a community-based organization. The main objective is to develop, document, and analyze a comprehensive sexual and reproductive healthcare package among FSWs in C&#244;te d'Ivoire.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;PRINCESSE is an open, single-arm interventional cohort of 500 FSWs in San Pedro (C&#244;te d'Ivoire) and its surroundings. Recruitment started on November 26&lt;sup class=&#034;typo_exposants&#034;&gt;th&lt;/sup&gt;, 2019 and is ongoing; the cohort is planned to last at least 30&#8201;months. The healthcare package (including HIV, hepatitis B, and sexually transmitted infection management, pregnancy screening, and contraception) is available both at mobile clinics organized for a quarterly follow-up (10 intervention sites, each site being visited every two weeks) and at a fixed clinic.&lt;/p&gt;
&lt;p&gt;Four waves of data collection were implemented: (i) clinical and safety data; (ii) socio-behavioral questionnaires; (iii) biological data; and (iv) in-depth interviews with female participants. Four additional waves of data collection are scheduled outside the cohort itself: (i) the medical and activity records of Aprosam for the PRINCESSE participants; (ii) the medical records of HIV+ FSW patients not participating in the PRINCESSE cohort, and routinely examined by Aprosam; (iii) in-depth interviews with key informants in the FSW community; and (iv) in-depth interviews with PRINCESSE follow-up actors.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Discussion&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The PRINCESSE project is one of the first interventions offering HIV oral PrEP as part of a more global sexual healthcare package targeting both HIV- and HIV+ women. Second, STIs and viral hepatitis B care were offered to all participants, regardless of their willingness to use PrEP. Another innovation is the implementation of mobile clinics for chronic/quarterly care. In terms of research, PRINCESSE is a comprehensive, interdisciplinary project combining clinical, biological, epidemiological, and social specific objectives and outcomes to document the operational challenges of a multidisease program in real-life conditions.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Trial registration&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The PRINCESSE project was registered on the Clinicaltrial.gov website (NCT03985085) on June 13, 2019.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>VIH, H&#233;patites virales, Sant&#233; sexuelle</title>
		<link>https://www.joseph.larmarange.net/VIH-Hepatites-virales-Sante</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/VIH-Hepatites-virales-Sante</guid>
		<dc:date>2020-09-18T08:41:18Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>
		<dc:subject>Universal Test &amp; Treat (UTT)</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;L'AFRAVIH &#8211; Alliance francophone des acteurs de sant&#233; contre le VIH et les infections virales chroniques &#8211; propose un ouvrage faisant le point des connaissances, des strat&#233;gies et des programmes d'actions &#224; conduire dans trois domaines cl&#233;s de la sant&#233; publique, trois d&#233;fis de dimension mondiale qui concernent l'ensemble des populations et dont l'intrication pose des questions de sant&#233; globale&#160;: la lutte contre le VIH et contre les h&#233;patites, avec la prise en compte de la sant&#233; sexuelle&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Universal-Test-Treat-UTT-+" rel="tag"&gt;Universal Test &amp; Treat (UTT)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L99xH150/arton278-821d0.png?1715146423' class='spip_logo spip_logo_right' width='99' height='150' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;L'AFRAVIH &#8211; Alliance francophone des acteurs de sant&#233; contre le VIH et les infections virales chroniques &#8211; propose un ouvrage faisant le point des connaissances, des strat&#233;gies et des programmes d'actions &#224; conduire dans trois domaines cl&#233;s de la sant&#233; publique, trois d&#233;fis de dimension mondiale qui concernent l'ensemble des populations et dont l'intrication pose des questions de sant&#233; globale&#160;: la lutte contre le VIH et contre les h&#233;patites, avec la prise en compte de la sant&#233; sexuelle comme &#233;l&#233;ment d&#233;terminant de la sant&#233;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;figure class='spip_document_271 spip_documents spip_documents_center media media_image media_image_png'&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L330xH500/livre_afravih_2020-df2ca-a2aab.png?1643664622' width='330' height='500' alt='PNG - 282.1 kio' /&gt;&lt;/figure&gt;&lt;h2 class=&#034;spip&#034;&gt;
Participation&lt;/h2&gt;
&lt;p&gt;J'y ai coordonn&#233; avec Jade Ghosn la section d&#233;di&#233;e &#224; la &lt;i&gt;Pr&#233;vention du VIH&lt;/i&gt; et j'y signe ou co-signe trois chapitres.&lt;/p&gt;
&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; &lt;abbr class=&#034;unapi-id&#034; title=&#034;2695N5KJ&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph (2020) &#171;&#160;Pr&#233;vention du VIH - Introduction&#160;&#187;, in &lt;span style=&#034;font-style: italic;&#034; &gt;VIH, H&#233;patites virales, Sant&#233; sexuelle&lt;/span&gt;, par Christine &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Katlama&lt;/span&gt;, Jade &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Ghosn&lt;/span&gt;, et Gilles &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Wandeler&lt;/span&gt;, Paris&#160;: AFRAVIH, EDP sciences, p. 683-686. ISBN&#160;: 978-2-7598-2403-8. https://www.livre-afravih.org/.&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt; &lt;abbr class=&#034;unapi-id&#034; title=&#034;APHVN9XK&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph (2020) &#171;&#160;Le Traitement antir&#233;troviral comme moyen de pr&#233;vention (TasP)&#160;&#187;, in &lt;span style=&#034;font-style: italic;&#034; &gt;VIH, H&#233;patites virales, Sant&#233; sexuelle&lt;/span&gt;, par Christine &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Katlama&lt;/span&gt;, Jade &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Ghosn&lt;/span&gt;, et Gilles &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Wandeler&lt;/span&gt;, Paris&#160;: AFRAVIH, EDP sciences, p. 702-711. ISBN&#160;: 978-2-7598-2403-8. https://www.livre-afravih.org/.&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt; &lt;abbr class=&#034;unapi-id&#034; title=&#034;AFGQI2XK&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Gantner&lt;/span&gt; Pierre, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Laurent&lt;/span&gt; Christian, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph et &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Ghosn&lt;/span&gt; Jade (2020) &#171;&#160;Prophylaxie pr&#233;exposition (PrEP)&#160;&#187;, in &lt;span style=&#034;font-style: italic;&#034; &gt;VIH, H&#233;patites virales, Sant&#233; sexuelle&lt;/span&gt;, par Christine &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Katlama&lt;/span&gt;, Jade &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Ghosn&lt;/span&gt;, et Gilles &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Wandeler&lt;/span&gt;, Paris&#160;: AFRAVIH, EDP sciences, p. 715-726. ISBN&#160;: 978-2-7598-2403-8. https://www.livre-afravih.org/.&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;L'ouvrage est accessible gratuitement en ligne&#160;: &lt;a href=&#034;https://www.livre-afravih.org/&#034; class=&#034;spip_url spip_out&#034; rel=&#034;external&#034;&gt;https://www.livre-afravih.org/&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/livre_afravih_prevention_introduction.pdf" length="440565" type="application/pdf" />
		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/livre_afravih_prep.pdf" length="851515" type="application/pdf" />
		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/livre_afravih_tasp.pdf" length="491262" type="application/pdf" />
		

	</item>
<item xml:lang="en">
		<title>Sexual health needs of female sex workers in C&#244;te d'Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention</title>
		<link>https://www.joseph.larmarange.net/Sexual-health-needs-of-female-sex-269</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/Sexual-health-needs-of-female-sex-269</guid>
		<dc:date>2020-01-09T12:21:05Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Partenaires sexuel(le)s</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Contraception</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Valentine Becquet, Marcellin Nouaman, M&#233;lanie Plazy, Jean-Marie Masumbuko, Camille Anoma, Soh Kouame, Christine Danel, Serge Paul Eholie, Joseph Larmarange for the ANRS 12361 PrEP-CI Study group &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Objective To describe sexual and reproductive health (SRH) needs of female sex workers (FSWs) to inform the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention in this population. &lt;br class='autobr' /&gt;
Design and setting The ANRS 12361 PrEP-CI cross-sectional and&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Partenaires-sexuel-le-s-+" rel="tag"&gt;Partenaires sexuel(le)s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Contraception-+" rel="tag"&gt;Contraception&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH85/arton269-92021.jpg?1715149525' class='spip_logo spip_logo_right' width='150' height='85' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Valentine Becquet, Marcellin Nouaman, M&#233;lanie Plazy, Jean-Marie Masumbuko, Camille Anoma, Soh Kouame, Christine Danel, Serge Paul Eholie, Joseph Larmarange for the ANRS 12361 PrEP-CI Study group&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Objective&lt;/strong&gt; To describe sexual and reproductive health (SRH) needs of female sex workers (FSWs) to inform the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention in this population.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Design and setting&lt;/strong&gt; The ANRS 12361 PrEP-CI cross-sectional and mixed-methods study was designed and implemented with two community-based organisations in C&#244;te d'Ivoire.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Participants&lt;/strong&gt; A convenience sample of 1000 FSWs aged &#8805;18, not known as HIV-positive, completed a standardised questionnaire assessing sociodemographic characteristics, sexual practices, use of community health services and a priori acceptability of PrEP. Twenty-two indepth interviews and eight focus group discussions were also conducted to document FSWs' risky practices and sexual behaviours, experiences with violence and discrimination, attitudes regarding HIV and sexually transmitted infections (STIs), and barriers to SRH services.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt; Although 87% described consistent condom use with clients, more than 22% declared accepting condomless sexual intercourse for a large sum of money. Furthermore, condom use with their steady partner and knowledge of their partner's HIV status were low despite their acknowledged concurrent sexual partnerships. While inconsistent condom use exposed FSWs to STIs and undesired pregnancies, the prevalence of contraceptive strategies other than condoms was low (39%) due to fear of contraception causing sterility. FSWs faced obstacles to accessing SRH care and preferred advice from their peers or self-medication.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusions&lt;/strong&gt; Despite adoption of preventive behaviour in most cases, FSWs are still highly exposed to HIV. Furthermore, FSWs seem to face several barriers to accessing SRH. Implementing PrEP among FSWs in West Africa, such as in C&#244;te d'Ivoire, constitutes an opportunity to consider the regular follow-up of HIV-negative FSWs. PrEP initiation should not condition access to SRH services; conversely, SRH services could be a way to attract FSWs into HIV prevention. Our results highlight the importance of developing a people-focused approach that integrates all SRH needs when transitioning from PrEP efficacy trials to implementation.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Reference&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;R9282HML&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Becquet&lt;/span&gt; Valentine, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Nouaman&lt;/span&gt; Marcellin, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Plazy&lt;/span&gt; M&#233;lanie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Masumbuko&lt;/span&gt; Jean-Marie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Anoma&lt;/span&gt; Camille, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Kouame&lt;/span&gt; Soh, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Danel&lt;/span&gt; Christine, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Eholie&lt;/span&gt; Serge Paul, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph et &lt;span style=&#034;font-variant: small-caps;&#034;&gt;ANRS 12361 PrEP-CI Study group&lt;/span&gt; (2020) &#171;&#160;Sexual health needs of female sex workers in C&#244;te d'Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention&#160;&#187;, &lt;span style=&#034;font-style: italic;&#034; &gt;BMJ Open&lt;/span&gt;, 10 (1) (janvier 1). DOI&#160;: 10.1136/bmjopen-2018-028508. https://bmjopen.bmj.com/content/10/1/e028508.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Sexual health needs of female sex workers reached by two NGOs in C&#244;te d'Ivoire: considerations for the future implementation of PrEP</title>
		<link>https://www.joseph.larmarange.net/Sexual-health-needs-of-female-sex</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/Sexual-health-needs-of-female-sex</guid>
		<dc:date>2019-07-31T12:18:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>In&#233;galit&#233;s de genre</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Organisation des soins</dc:subject>
		<dc:subject>Partenaires sexuel(le)s</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Oral communication presented at AIDS Impact 2019, July 31, 2019, in London. &lt;br class='autobr' /&gt; Authors &lt;br class='autobr' /&gt;
Valentine Becquet, Marcellin Nouaman, M&#233;lanie Plazy, Jean-Marie Masumbuko, Camille Anoma, Soh Kouam&#233;, Christine Danel, Serge Eholi&#233;, Joseph Larmarange &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Aim &lt;br class='autobr' /&gt;
In West Africa, most countries have mixed HIV epidemics; new tools such as pre-exposure prophylaxis (PrEP) should target in priority most affected populations, particularly female sex workers (FSWs). This paper describes sexual and&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Inegalites-de-genre-+" rel="tag"&gt;In&#233;galit&#233;s de genre&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Organisation-des-soins-+" rel="tag"&gt;Organisation des soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Partenaires-sexuel-le-s-+" rel="tag"&gt;Partenaires sexuel(le)s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH84/arton257-58ed0.jpg?1715149525' class='spip_logo spip_logo_right' width='150' height='84' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Oral communication presented at &lt;a href=&#034;http://www.aidsimpact.com/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;AIDS Impact 2019&lt;/a&gt;, July 31, 2019, in London.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Valentine Becquet, Marcellin Nouaman, M&#233;lanie Plazy, Jean-Marie Masumbuko, Camille Anoma, Soh Kouam&#233;, Christine Danel, Serge Eholi&#233;, Joseph Larmarange&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Aim&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;In West Africa, most countries have mixed HIV epidemics; new tools such as pre-exposure prophylaxis (PrEP) should target in priority most affected populations, particularly female sex workers (FSWs). This paper describes sexual and reproductive health (SRH) needs of FSWs in C&#244;te d'Ivoire to inform the future implementation of PrEP in this population.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Method/Issue&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The ANRS 12361 PrEP-CI cross-sectional and mixed-methods study was designed and implemented with two Ivorian community-based organizations. 1000 FSWs completed a standardized questionnaire assessing women's sociodemographic characteristics, sexual practices and behaviors, use of community health services, a priori acceptability of PrEP. Twenty-two in-depth interviews and eight focus group discussions were conducted at prostitution sites. FSWs were interviewed about risky practices and sexual behaviors, experiences with violence and discrimination, attitudes regarding HIV and sexually transmitted infections (STIs), and barriers to SRH services.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results/Comments&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The quantitative and qualitative results showed that FSWs were highly exposed to HIV despite their use of condoms with clients. 91% did not use condoms with their regular partner, despite their acknowledged concurrent sexual partnerships. 23% accepted condomless sexual intercourse for a large sum of money, especially when they had had few previous clients. Moreover, FSWs faced many unmet needs regarding SRH beyond HIV prevention and treatment. Inconsistent condom use exposed FSWs to STIs and undesired pregnancies. However, the prevalence of contraceptive use was low (40%) due to fear of contraception causing sterility. FSWs faced obstacles in accessing SRH care and preferred advice from their peers or self-medication.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Discussion&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Implementing PrEP among FSWs in West Africa, such as in C&#244;te d'Ivoire, constitutes an opportunity to consider the chronic follow-up of HIV-negative FSWs. PrEP initiation should not condition access to SRH services; conversely, SRH services could be a way to attract FSWs into practicing HIV prevention. Our results highlight the importance of developing a people-focused approach that integrates all SRH needs when transitioning from PrEP efficacy trials to implementation.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Reference&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;3QLN987L&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Becquet&lt;/span&gt; Valentine, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Nouaman&lt;/span&gt; Marcellin, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Plazy&lt;/span&gt; M&#233;lanie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Masumbuko&lt;/span&gt; Jean-Marie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Anoma&lt;/span&gt; Camille, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Kouam&#233;&lt;/span&gt; Soh, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Danel&lt;/span&gt; Christine, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Eholi&#233;&lt;/span&gt; Serge et &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph (2019) &#171;&#160;Sexual health needs of female sex workers reached by two NGOs in C&#244;te d'Ivoire: considerations for the future implementation of PrEP&#160;&#187; (communication orale), pr&#233;sent&#233; &#224; &lt;span style=&#034;font-style: italic;&#034; &gt;AIDS Impact&lt;/span&gt;, London. http://www.aidsimpact.com/abstracts/-LZFgxedD3IcXCPGWlOB.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>No effect of test and treat on sexual behaviours at population level in rural South Africa</title>
		<link>https://www.joseph.larmarange.net/No-effect-of-test-and-treat-on</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/No-effect-of-test-and-treat-on</guid>
		<dc:date>2019-03-06T00:15:31Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Afrique du Sud</dc:subject>
		<dc:subject>TasP (ANRS 12249)</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>
		<dc:subject>Universal Test &amp; Treat (UTT)</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Rolland Matthieu, McGrath Nuala, Tiendrebeogo Thierry, Larmarange Joseph, Pillay Deenan, Dabis Fran&#231;ois, Orne-Gliemann Joanna for the ANRS 12249 TasP study group &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Context: Within the community-randomized ANRS 12249 Treatment-as-Prevention trial conducted in rural South Africa, we analysed sexual behaviours stratified by sex over time, comparing immediate antiretroviral therapy irrespective of CD4+ cell count vs. CD4+-guided antiretroviral therapy (start at CD4+ cell&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Afrique-du-Sud-+" rel="tag"&gt;Afrique du Sud&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-TasP-ANRS-12249-97-+" rel="tag"&gt;TasP (ANRS 12249)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Universal-Test-Treat-UTT-+" rel="tag"&gt;Universal Test &amp; Treat (UTT)&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH103/arton247-4b2ba.jpg?1715149527' class='spip_logo spip_logo_right' width='150' height='103' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Rolland Matthieu, McGrath Nuala, Tiendrebeogo Thierry, Larmarange Joseph, Pillay Deenan, Dabis Fran&#231;ois, Orne-Gliemann Joanna for the ANRS 12249 TasP study group&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Context:&lt;/strong&gt; Within the community-randomized ANRS 12249 Treatment-as-Prevention trial conducted in rural South Africa, we analysed sexual behaviours stratified by sex over time, comparing immediate antiretroviral therapy irrespective of CD4+ cell count vs. CD4+-guided antiretroviral therapy (start at CD4+ cell count &gt; 350 cells/&#956;l then &gt;500 cells/&#956;l) arms.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods:&lt;/strong&gt; As part of the 6-monthly home-based trial rounds, a sexual behaviour individual questionnaire was administered to all residents at least 16 years. We considered seven indicators: sexual intercourse in the past month; at least one regular sexual partner in the past 6 months; at least one casual sexual partner in the past 6 months and more than one sexual partner in the past 6 months; condom use at last sex (CLS) with regular partner, CLS with casual partner, and point prevalence estimate of concurrency. We conducted repeated cross-sectional analyses, stratified by sex. Generalized Estimating Equations models were used, including trial arm, trial time, calendar time and interaction between trial arm and trial time.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results:&lt;/strong&gt; CLS with regular partner varied between 29&#8211;51% and 23&#8211;46% for men and women, respectively, with significantly lower odds among women in the control vs. intervention arm by trial end (P &lt; 0.001). CLS with casual partner among men showed a significant interaction between arm and trial round, with no consistent pattern. Women declared more than one partner in the past 6 months in less than 1% of individual questionnaires; among men, rates varied between 5&#8211;12%, and odds significantly and continuously declined between calendar rounds 1 and 7 [odds ratio = 4.2 (3.24&#8211;5.45)].&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusion:&lt;/strong&gt; Universal Test and Treat was not associated with increased sexual risk behaviours.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Reference&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;P3429VGJ&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Rolland&lt;/span&gt; Matthieu, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;McGrath&lt;/span&gt; Nuala, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Tiendrebeogo&lt;/span&gt; Thierry, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Pillay&lt;/span&gt; Deenan, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Dabis&lt;/span&gt; Fran&#231;ois, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Orne-Gliemann&lt;/span&gt; Joanna et &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Group&lt;/span&gt; for the ANRS 12249 TasP study (2019) &#171;&#160;No effect of test and treat on sexual behaviours at population level in rural South Africa&#160;&#187;, &lt;span style=&#034;font-style: italic;&#034; &gt;AIDS&lt;/span&gt;, 33 (4) (mars 15), p.&#160;709. DOI&#160;: 10.1097/qad.0000000000002104. https://journals.lww.com/aidsonline/Abstract/2019/03150/No_effect_of_test_and_treat_on_sexual_behaviours.14.aspx.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>PRINCESSE &#183; PrEP, infections sexuellement transmissibles, contraception, h&#233;patite virale B, sant&#233; sexuelle pour les travailleuses du sexe en C&#244;te d'Ivoire</title>
		<link>https://www.joseph.larmarange.net/PRINCESSE-PrEP-infections</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/PRINCESSE-PrEP-infections</guid>
		<dc:date>2018-07-19T10:22:40Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Itin&#233;raires th&#233;rapeutiques</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>Adh&#233;rence</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>R&#233;tention dans les soins</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>

		<description>
&lt;p&gt;Responsables scientifiques Joseph LARMARANGE (Ceped) Serge EHOLIE (PAC-CI) &lt;br class='autobr' /&gt;
Partenariat PAC-CI Aprosam H&#244;pital Saint-Antoine ISPED &lt;br class='autobr' /&gt;
Financement Agence Nationale de Recherche sur le Sida et les h&#233;patites virales (ANRS) &lt;br class='autobr' /&gt;
Enregistrement sur clinicaltrials.org &lt;br class='autobr' /&gt;
NCT03985085 &lt;br class='autobr' /&gt;
R&#233;sum&#233; &lt;br class='autobr' /&gt;
Suite aux r&#233;sultats du projet exploratoire PrEP-CI (ANRS 12361) portant sur la question de la faisabilit&#233; et de la pertinence d'un programme PrEP aupr&#232;s des travailleuses du sexe (TS) en C&#244;te d'Ivoire, nous&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Projets-de-Recherche-" rel="directory"&gt;Projets de Recherche&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Itineraires-therapeutiques-+" rel="tag"&gt;Itin&#233;raires th&#233;rapeutiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Adherence-+" rel="tag"&gt;Adh&#233;rence&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Retention-dans-les-soins-+" rel="tag"&gt;R&#233;tention dans les soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH75/arton235-728f2.jpg?1643664440' class='spip_logo spip_logo_right' width='150' height='75' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Responsables scientifiques&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Joseph LARMARANGE (Ceped)&lt;/li&gt;&lt;li&gt; Serge EHOLIE (PAC-CI)&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Partenariat&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; &lt;a href=&#034;http://www.pac-ci.org/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;PAC-CI&lt;/a&gt;&lt;/li&gt;&lt;li&gt; Aprosam&lt;/li&gt;&lt;li&gt; &lt;a href=&#034;http://saintantoine.aphp.fr/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;H&#244;pital Saint-Antoine&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &lt;a href=&#034;http://www.isped.u-bordeaux.fr/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;ISPED&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Financement&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; &lt;a href=&#034;http://www.anrs.fr&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;Agence Nationale de Recherche sur le Sida et les h&#233;patites virales (ANRS)&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Enregistrement sur clinicaltrials.org&lt;/h2&gt;
&lt;p&gt;&lt;a href=&#034;https://clinicaltrials.gov/ct2/show/NCT03985085&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;NCT03985085&lt;/a&gt;&lt;/p&gt;
&lt;figure class='spip_document_243 spip_documents spip_documents_center media media_image media_image_png'&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L640xH248/princesse_logo_couleur-13bb8.png?1643664441' width='640' height='248' alt='PNG - 129.5 kio' /&gt;&lt;/figure&gt;&lt;h2 class=&#034;spip&#034;&gt;
R&#233;sum&#233;&lt;/h2&gt;
&lt;p&gt;Suite aux r&#233;sultats du projet exploratoire &lt;a href='https://www.joseph.larmarange.net/Etude-de-faisabilite-en-vue-d-un' class=&#034;spip_in&#034;&gt;PrEP-CI (ANRS 12361)&lt;/a&gt; portant sur la question de la faisabilit&#233; et de la pertinence d'un programme PrEP aupr&#232;s des travailleuses du sexe (TS) en C&#244;te d'Ivoire, nous avons con&#231;u, conjointement avec les acteurs communautaires ivoiriens, une intervention de sant&#233; d&#233;nomm&#233;e PRINCESSE, portant sur une offre de soins globale en sant&#233; sexuelle et reproductive &#224; destination des travailleuses du sexe de la r&#233;gion de San Pedro.&lt;/p&gt;
&lt;p&gt;L'originalit&#233; de cette intervention r&#233;side dans la combinaison d'une offre de prophylaxie pr&#233;exposition VIH (pour les TS VIH-) avec une prise en charge pr&#233;coce des femmes VIH+, la prise en compte de l'infection au VHB (d&#233;pistage, vaccination et traitement), le d&#233;pistage et le traitement des infections sexuellement transmissibles et de leurs cons&#233;quences, une offre de contraception, un conseil en gestion des menstrues et le rep&#233;rage des situations de d&#233;pendance. La mise en &#339;uvre de ce dispositif sera r&#233;alis&#233;e en partenariat avec une ONG communautaire (Aprosam), au travers de sa clinique fixe d&#233;j&#224; existante et d'une clinique mobile adapt&#233;e &#224; un suivi trimestriel directement sur les sites prostitutionnels.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Objectif principal&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;D&#233;velopper, documenter et analyser une offre de soins communautaire combinant d&#233;pistage, pr&#233;vention combin&#233;e dont prophylaxie pr&#233;exposition (PrEP), traitement imm&#233;diat du VIH, prise en charge de l'h&#233;patite B et sant&#233; sexuelle et reproductive (SSR) afin de r&#233;duire l'exposition au VIH des travailleuses du sexe (TS) et de leurs partenaires en C&#244;te d'Ivoire.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Objectifs secondaires&lt;/strong&gt;&lt;/p&gt;
&lt;ol class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Analyser l'acc&#232;s aux soins et la r&#233;tention, et plus g&#233;n&#233;ralement le parcours de soins des participantes, dans un suivi trimestriel des TS (infect&#233;es ou non par le VIH)&lt;/li&gt;&lt;li&gt; Mesurer l'&#233;volution au cours du temps de l'&#233;tat de sant&#233; des participantes via des indicateurs cliniques, comportementaux et sociaux&lt;/li&gt;&lt;li&gt; &#201;valuer l'initiation, les usages et l'observance &#224; la PrEP&lt;/li&gt;&lt;li&gt; Comparer la prise en charge VIH dans le dispositif PRINCESSE avec la prise en charge en routine existante&lt;/li&gt;&lt;li&gt; Mesurer le d&#233;pistage, la vaccination et le traitement de l'h&#233;patite B dans le cadre d'une prise en charge d&#233;centralis&#233;e int&#233;gr&#233;e &#224; une offre de PrEP VIH ainsi que les interactions &#233;ventuelles entre PrEP VIH et infection au VHB&lt;/li&gt;&lt;li&gt; Documenter les cons&#233;quences (positives ou n&#233;gatives) non pr&#233;vues du dispositif PRINCESSE sur le quotidien des participantes en particulier et sur le march&#233; du travail du sexe en g&#233;n&#233;ral&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;strong&gt;M&#233;thodologie&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Le dispositif PRINCESSE est une cohorte interventionnelle mono-bras de 500 travailleuses du sexe &#224; San Pedro (400 VIH- et 100 VIH+).&lt;/p&gt;
&lt;p&gt;Quatre dispositifs de collecte de donn&#233;es sont int&#233;gr&#233;s &#224; la cohorte&#160;: (i) donn&#233;es cliniques et de pharmacovigilance, (ii) questionnaires socio-comportementaux, (iii) donn&#233;es biologiques et (iv) entretiens approfondis avec les participantes.&lt;/p&gt;
&lt;p&gt;Quatre collectes additionnelles sont pr&#233;vues en dehors de la cohorte elle-m&#234;me&#160;: (i) la capture des registres d'activit&#233;s en strat&#233;gie avanc&#233;e des paires &#233;ducatrices&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; (ii) la capture des dossiers m&#233;dicaux des patientes VIH+ ne participant pas &#224; la cohorte PRINCESSE et vues en routine par l'ONG partenaires&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; (iii) des entretiens approfondis avec des informateurs-trices cl&#233;s dans la communaut&#233; des TS&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; (iv) des entretiens approfondis avec les acteurs du suivi PRINCESSE (paires-&#233;ducatrices et soignants).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Nombre de participantes&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;500 participantes (100 VIH+ et 400 VIH-)&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Crit&#232;res de jugement&lt;/strong&gt;&lt;/p&gt;
&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Taux de compl&#233;tion des visites trimestrielles.&lt;/li&gt;&lt;li&gt; Proportion avec au moins une IST &#224; M0, M12 et M24&lt;/li&gt;&lt;li&gt; Survenue d'une grossesse non d&#233;sir&#233;e&lt;/li&gt;&lt;li&gt; Initiation de la PrEP&lt;/li&gt;&lt;li&gt; Observance &#224; la PrEP&lt;/li&gt;&lt;li&gt; R&#233;tention dans les soins VIH &#224; M18&lt;/li&gt;&lt;li&gt; Survenue d'un &#233;chec virologique&lt;/li&gt;&lt;li&gt; Taux de vaccination VHB&lt;/li&gt;&lt;li&gt; &#201;volution au cours du temps de la charge virale VHB et du niveau de Fibrose (mesur&#233;e par l'algorithme FIB-4)&lt;/li&gt;&lt;li&gt; Augmentation des transaminases (flares) apr&#232;s l'arr&#234;t de la PrEP&lt;/li&gt;&lt;li&gt; &#201;valuation qualitative des &#233;v&#232;nements sociaux ind&#233;sirables survenus dans le quotidien des participantes et des non participantes&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Intervention&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Mise en &#339;uvre d'une offre de soins globale en sant&#233; sexuelle et reproductive &#224; destination des travailleuses (TS) du sexe en C&#244;te d'Ivoire, combinant une offre de PrEP VIH (pour les TS VIH-) avec une prise en charge pr&#233;coce des femmes VIH+, la prise en compte de l'infection par le VHB (d&#233;pistage, vaccination et traitement), le d&#233;pistage et le traitement des infections sexuellement transmissibles (IST) et de leurs cons&#233;quences, une offre de contraception, un d&#233;pistage trimestriel des grossesses, un conseil en gestion des menstrues et le rep&#233;rage des situations de d&#233;pendance.&lt;br class='autobr' /&gt;
Cette offre de sant&#233; sera disponible &#224; la fois dans des cliniques mobiles organis&#233;es pour un suivi trimestriel (10 sites d'interventions, chaque site &#233;tant visit&#233; toutes les deux semaines) et dans la clinique fixe de l'ONG communautaire partenaire, au choix de chaque participante.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Enregistrement&lt;/h2&gt;
&lt;p&gt;ClinicalTrials.gov Identifier&#160;: &lt;a href=&#034;https://clinicaltrials.gov/ct2/show/NCT03985085&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;NCT03985085&lt;/a&gt;&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Mots-Cl&#233;s&lt;/h2&gt;
&lt;p&gt;VIH/Sida, H&#233;patites virales, PrEP, Sant&#233; sexuelle et reproductive, D&#233;pistage, Pr&#233;vention, Traitement, Travail du Sexe, Cliniques mobiles.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Zone g&#233;ographique&lt;/h2&gt;
&lt;p&gt;C&#244;te d'Ivoire&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Calendrier&lt;/h2&gt;
&lt;p&gt;2018-2021&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Publications&lt;/h2&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5324982&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://theses.hal.science/tel-05324982v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-e4dcfbc0-35d21.png?1764804943' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://theses.hal.science/tel-05324982v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;&#201;valuation des infections sexuellement transmissibles dans une strat&#233;gie avanc&#233;e d'offre combin&#233;e de sant&#233; sexuelle dont la prophylaxie pr&#233;exposition chez des travailleuses du sexe en C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731597542&#034; class=&#034;hal-auteur&#034;&gt;N'z&#233;bo Marcellin Nouaman&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;M&#233;decine humaine et pathologie. Universit&#233; de Bordeaux, 2025. Fran&#231;ais. &lt;a target=&#034;_blank&#034; href=&#034;https://www.theses.fr/2025BORD0173&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;NNT : 2025BORD0173&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-these&#034;&gt;Th&#232;se&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://theses.hal.science/tel-05324982v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;tel-05324982&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-5163769&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05163769v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163769v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Perceptions regarding long-acting pre-exposure prevention (PrEP) among female sex workers and men having sex with men in San Pedro and Abidjan, C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;IAS 2025, the 13th IAS Conference on HIV Science&lt;/i&gt;, Jul 2025, Kigali, Rwanda. &lt;a target=&#034;_blank&#034; href=&#034;https://programme.ias2025.org/Abstract/Abstract/?abstractid=4762&#034; rel=&#034;noreferrer noopener&#034;&gt;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-poster&#034;&gt;Poster de conf&#233;rence&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163769v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05163769&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-5163756&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05163730v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH43/thumb-1a4ce10f-3d2ff.png?1752686173' alt=&#034;Image document&#034; width='75' height='43' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163730v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Adoption of HIV preexposure prophylaxis (PrEP) among female sex workers (FSWs) in C&#244;te d'Ivoire: complex trajectories and early adopters&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;IAS 2025, the 13th IAS Conference on HIV Science&lt;/i&gt;, International AIDS Society, Jul 2025, Kigali, Rwanda&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163730v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05163730&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-5090841&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05090841v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05090841v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Adoption of HIV preexposure prophylaxis (PrEP) among female sex workers (FSWs) in C&#244;te d'Ivoire: complex trajectories and early adopters&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;16th AIDSImpact Conference&lt;/i&gt;, AIDSImpact, May 2025, Casablanca, Morocco&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05090841v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05090841&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-5090784&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05090784v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05090784v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Perception de la Prophylaxie pr&#233;exposition &#224; longue dur&#233;e d'action chez les travailleuses du sexe et les HSH &#224; San Pedro et Abidjan, C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;16th AIDSImpact Conference&lt;/i&gt;, AIDSImpact, May 2025, Casablanca, Maroc&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05090784v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05090784&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-5460133&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05460133v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05460133v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Sex work in Bolivia during the Covid-19 crisis: intersectional impact and adaptative strategies&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Juliana+Castro+Avila&#034; class=&#034;hal-auteur&#034;&gt;Juliana Castro Avila&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Harold+Mendoza&#034; class=&#034;hal-auteur&#034;&gt;Harold Mendoza&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731522411&#034; class=&#034;hal-auteur&#034;&gt;Nicolas Lorente&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/marion-di-ciaccio&#034; class=&#034;hal-auteur&#034;&gt;Marion Di Ciaccio&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Edgar+Valdez&#034; class=&#034;hal-auteur&#034;&gt;Edgar Valdez&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/daniela-rojas-castro&#034; class=&#034;hal-auteur&#034;&gt;Daniela Rojas Castro&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;16th AIDSImpact Conference&lt;/i&gt;, AIDSImpact, May 2025, Casablanca, Morocco&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05460133v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05460133&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-5090854&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05090854v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH43/thumb-d8b72e14-84654.png?1749790466' alt=&#034;Image document&#034; width='75' height='43' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05090854v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Le&#231;ons apprises du projet ANRS 12381 PRINCESSE en C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Aline+Agoua&#034; class=&#034;hal-auteur&#034;&gt;Aline Agoua&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Herv%C3%A9+Dao&#034; class=&#034;hal-auteur&#034;&gt;Herv&#233; Dao&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Mama+Kate&#034; class=&#034;hal-auteur&#034;&gt;Mama Kate&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197956&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Cl%C3%A9mence+Z%C3%A9bago&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Z&#233;bago&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Chef+d%27%C3%89tat+Major&#034; class=&#034;hal-auteur&#034;&gt;Chef d'&#201;tat Major&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731391380&#034; class=&#034;hal-auteur&#034;&gt;Hector Juliard&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;2025&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-video&#034;&gt;Vid&#233;o&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05090854v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05090854&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-4990249&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04990223v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-4596acf7-a3a62.png?1741981009' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04990223v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Syndromic and biological screening for sexually transmitted infections in female sex workers in C&#244;te d'Ivoire: the ANRS 12381 PRINCESSE cohort study&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marcellin+N%E2%80%99zebo+Nouaman&#034; class=&#034;hal-auteur&#034;&gt;Marcellin N'zebo Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Patrick+Ahuatchi+Coffie&#034; class=&#034;hal-auteur&#034;&gt;Patrick Ahuatchi Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Aline+Agoua&#034; class=&#034;hal-auteur&#034;&gt;Aline Agoua&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Cl%C3%A9mence+Z%C3%A9bago&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Z&#233;bago&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Herv%C3%A9+Dao&#034; class=&#034;hal-auteur&#034;&gt;Herv&#233; Dao&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=S%C3%A9verin+Lenaud&#034; class=&#034;hal-auteur&#034;&gt;S&#233;verin Lenaud&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Mian+Anatole&#034; class=&#034;hal-auteur&#034;&gt;Mian Anatole&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Valentine+Becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196998&#034; class=&#034;hal-auteur&#034;&gt;Fran&#231;ois Dabis&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Serge+Eholie&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;Frontiers in Public Health&lt;/i&gt;, 2025, 13, &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.3389/fpubh.2025.1535122&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.3389/fpubh.2025.1535122&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04990223v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04990223&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-4815260&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04815258v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-03b53679-98aa0.png?1733856007' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04815258v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;VIH : des solutions pr&#233;ventives &#224; longue dur&#233;e prometteuses&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Louise+Hurel&#034; class=&#034;hal-auteur&#034;&gt;Louise Hurel&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731241921&#034; class=&#034;hal-auteur&#034;&gt;Christian Laurent&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/karna-coulibaly&#034; class=&#034;hal-auteur&#034;&gt;Karna Coulibaly&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;2024&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-blog&#034;&gt;Article de blog scientifique&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04815258v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04815258&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-4715381&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04715381v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04715381v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Documentation des tables analytiques de la cohorte 2019-2023 du projet PRINCESSE (C&#244;te d'Ivoire)&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197956&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Aline+Agoua&#034; class=&#034;hal-auteur&#034;&gt;Aline Agoua&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Cl%C3%A9mence+Z%C3%A9bago&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Z&#233;bago&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Herv%C3%A9+Dao&#034; class=&#034;hal-auteur&#034;&gt;Herv&#233; Dao&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/aude-jary&#034; class=&#034;hal-auteur&#034;&gt;Aude Jary&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;Institut de Recherche pour le D&#233;veloppement (IRD). 2024&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-report&#034;&gt;Rapport&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04715381v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04715381&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-more hal-more-collection&#034;&gt;&lt;a href=&#034;https://hal.science/ANRS_12381_PRINCESSE&#034;&gt;Voir la liste compl&#232;te des publications&lt;/a&gt;&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>Mod&#233;lisation &#224; l'&#233;chelle du district sanitaire de l'incidence VIH et de la cascade de soins pour optimiser les politiques de contr&#244;le en C&#244;te d'Ivoire</title>
		<link>https://www.joseph.larmarange.net/Modelisation-a-l-echelle-du</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/Modelisation-a-l-echelle-du</guid>
		<dc:date>2018-01-19T14:53:49Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>Adh&#233;rence</dc:subject>
		<dc:subject>Lien vers les soins</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>R&#233;tention dans les soins</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Model CI</dc:subject>

		<description>
&lt;p&gt;Responsables scientifiques Joseph LARMARANGE Eric OUATTARA (PAC-CI) &lt;br class='autobr' /&gt;
Partenariat PAC-CI (site ANRS de C&#244;te d'Ivoire) Inserm U219, Bordeaux Laboratoire MESuRS, CNAM Paris Imperial College London Institut Pierre Louis d'&#233;pid&#233;miologie et de sant&#233; publique (UMRS 1136), Paris &lt;br class='autobr' /&gt;
Financement Agence Nationale de Recherche sur le Sida et les h&#233;patites virales (ANRS) &lt;br class='autobr' /&gt;
R&#233;sum&#233; &lt;br class='autobr' /&gt;
Objectif de la recherche&#160;: Les politiques actuelles de d&#233;pistage en C&#244;te d'Ivoire se basant sur les &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;Hotspot&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187; de&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Projets-de-Recherche-" rel="directory"&gt;Projets de Recherche&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Adherence-+" rel="tag"&gt;Adh&#233;rence&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Entree-en-soins-+" rel="tag"&gt;Lien vers les soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Retention-dans-les-soins-+" rel="tag"&gt;R&#233;tention dans les soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Model-CI-+" rel="tag"&gt;Model CI&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH135/arton223-a9e32.jpg?1715148398' class='spip_logo spip_logo_right' width='150' height='135' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Responsables scientifiques&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Joseph LARMARANGE&lt;/li&gt;&lt;li&gt; Eric OUATTARA (PAC-CI)&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Partenariat&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; &lt;a href=&#034;http://www.pacci.ci/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;PAC-CI (site ANRS de C&#244;te d'Ivoire)&lt;/a&gt;&lt;/li&gt;&lt;li&gt; Inserm U219, Bordeaux&lt;/li&gt;&lt;li&gt; Laboratoire MESuRS, CNAM Paris&lt;/li&gt;&lt;li&gt; Imperial College London&lt;/li&gt;&lt;li&gt; Institut Pierre Louis d'&#233;pid&#233;miologie et de sant&#233; publique (UMRS 1136), Paris&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Financement&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; &lt;a href=&#034;http://www.anrs.fr&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;Agence Nationale de Recherche sur le Sida et les h&#233;patites virales (ANRS)&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
R&#233;sum&#233;&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Objectif de la recherche&#160;:&lt;/strong&gt; Les politiques actuelles de d&#233;pistage en C&#244;te d'Ivoire se basant sur les &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;Hotspot&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187; de pr&#233;valence, peine &#224; atteindre les personnes les plus &#224; risque de transmission. Estimer l'incidence, meilleur reflet de la dynamique du VIH au niveau des districts sanitaires sera essentiel pour optimiser les politiques de d&#233;pistage et de pr&#233;vention en C&#244;te d'Ivoire. L'objectif de ce contrat d'initiation est d'&#233;valuer la faisabilit&#233; de l'estimation de l'incidence du VIH et la cascade des soins au niveau des districts sanitaires &#224; partir de mod&#232;les et donn&#233;es existantes en C&#244;te d'Ivoire. Les objectifs sp&#233;cifiques sont&#160;: (i) identifier les sources de donn&#233;es n&#233;cessaires pour estimer l'incidence du VIH et la cascade de soins au niveau des districts sanitaires&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; (ii) Explorer et voir dans quelle mesure l'on pourrait adapter deux mod&#232;les existants pour estimer l'incidence du VIH au niveau des districts sanitaires en C&#244;te d'voire.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Situation du sujet&#160;:&lt;/strong&gt; Les limites aux politiques de d&#233;pistage sont&#160;: (i) une offre limit&#233;e de d&#233;pistage &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;passive&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187; ou &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;active&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;&#160;: 90% des pays d'Afrique subsaharienne ont adopt&#233;s les recommandations de d&#233;pistage dans les centres pr&#233;nataux mais seul 40% l'appliquent&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; (ii) des difficult&#233;s &#224; atteindre les personnes &#224; risques comme les adolescents&#160;: entre 2005 et 2012, les d&#233;c&#232;s li&#233;s au VIH chez eux ont augment&#233; de 50%&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; (iii) des lacunes dans la cascade se soin&#160;: plus de 40% des personnes d&#233;pist&#233;es positifs ne sont pas pris en charge pour l'initiation du traitement ARV. Ce nombre devrait diminuer avec l'adoption du traitement ARV pr&#233;coce. En dehors des limites li&#233;es &#224; l'offre, les freins aux d&#233;pistages li&#233;s au contexte social ou aux caract&#233;ristiques des personnes doivent &#234;tre pris en compte dans contexte de la Cote d'Ivoire ou la pr&#233;valence du VIH est de 3.2% et l'incidence &#233;lev&#233;e dans les r&#233;gions du sud-ouest et d'Abidjan. Les mod&#232;les &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;statistiques&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187; de r&#233;tro-calculs et les mod&#232;les &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;math&#233;matiques&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187; de transmission sont essentiels pour l'estimation de l'incidence mais estime rarement l'incidence infranationale &#224; cause du manque donn&#233;es fiables.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;M&#233;thodes&#160;:&lt;/strong&gt; coordonn&#233;s par un groupe de travail multidisciplinaire&#160;: 1) Recueil des donn&#233;es&#160;: (i) revue de la litt&#233;rature&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; (ii) rencontre des autorit&#233;s et partenaires du VIH&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; (iii) Analyse et r&#233;daction d'un document de synth&#232;se. 2) Explorer l'adaptation de deux mod&#232;les existants&#160;: Workshop pour discuter de l'adaptation des mod&#232;les et/ou du d&#233;veloppement d'un nouveau mod&#232;le.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;R&#233;sultats attendus et perspectives&#160;:&lt;/strong&gt; Etape pr&#233;liminaire pour d&#233;velopper un mod&#232;le d'estimation de l'incidence du VIH et la cascade des soins par district sanitaire pour &#233;valuer l'efficacit&#233; de strat&#233;gies de pr&#233;vention et de d&#233;pistages bas&#233;e sur l'incidence afin d'optimiser la politique de contr&#244;le du VIH en C&#244;te d'Ivoire.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Mots-Cl&#233;s&lt;/h2&gt;
&lt;p&gt;Mod&#233;lisation, VIH/SIDA, Incidence par district sanitaire, cascade de soins&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Zone g&#233;ographique&lt;/h2&gt;
&lt;p&gt;C&#244;te d'Ivoire&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Calendrier&lt;/h2&gt;
&lt;p&gt;2018-2019&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>



</channel>

</rss>
